3 New Strong Buy Ratings from Top-Rated Analysts: 05/29/2026

All of these stocks are very different, but they have one important thing in common: Analysts love ‘em. 

• Interface (TILE) — Modular flooring leader targets 25% upside ahead.
• Workiva (WK) — Compliance SaaS play eyes massive 60% upside surge.
• ANI Pharmaceuticals (ANIP) — Rare disease innovator targets 35% upside on raised guidance. 

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...

1. Interface (NASDAQ: TILE)

Interface is a modular flooring company that designs, produces, and sells modular carpet products primarily in the Americas, Europe, and the Asia-Pacific, with a focus on sustainable and innovative flooring solutions. The company recently beat Q1 2026 earnings estimates and declared a regular quarterly dividend, demonstrating both operational strength and shareholder-friendly capital allocation.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $29.13 — get current quote

Max 1-year forecast: $36.00

Why we're watching:

• Analyst support: The stock has 1 Strong Buy and 1 Buy rating from 2 analysts, both sharing a consensus $36 price target representing about 25% upside potential. See the ratings
• Benchmark's Reuben Garner (a top 14% rated analyst) recently initiated coverage on TILE with a Strong Buy rating and $36 price target, recognizing the company's market position and growth potential in the modular flooring space.
• The company beat Q1 earnings and revenue estimates while maintaining its dividend, demonstrating financial discipline and consistent cash generation with $13.5M in operating cash flow supporting shareholder returns.
• Industry ranking context: TILE is currently the 1st highest-rated stock in the Building Product & Equipment industry. But be cautious: it has an Industry Rating of D, presenting a potential headwind. 
• Zen Rating highlights: TILE is in the top 5% of stocks we track based on fundamentals, earning an overall Zen Rating of A. 
• Component Grades: The company earned a B in Value given its reasonable 13.36x P/E ratio, B in Safety with a conservative debt-to-equity ratio of 0.9, B in Financials reflecting strong balance sheet fundamentals, B in Sentiment from positive analyst coverage, and B in Artificial Intelligence reflecting its innovative product development capabilities. (See all 7 Zen Component Grades here)

2. ANI Pharmaceuticals (NASDAQ: ANIP)

ANI Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals across the United States and Canada, with a strategic shift toward higher-margin rare disease products. The company is experiencing strong momentum with Cortrophin Gel and recently raised its 2026 outlook following a Q1 earnings beat.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $82.77 — get current quote

Max 1-year forecast: $124.00

Why we're watching:

• Analyst support: Both analysts covering ANIP rate it a Strong Buy, with an average price target of $112.00 representing 35.4% upside from current levels. See the ratings
• Guggenheim's Vamil Divan (a top 3% rated analyst) maintained his Strong Buy rating with the highest price target of $124, expressing strong confidence in the company's growth trajectory driven by new product launches and market expansion, with particular emphasis on the potential for earnings growth and efficient operational structure.
• Barclays analyst recently initiated coverage with a Strong Buy rating and $100 price target, highlighting ANIP's innovative pipeline and its ability to capture market share through strategic partnerships that are expected to enhance product availability and drive significant revenue growth.
• The company raised its full-year 2026 guidance following strong Q1 results, demonstrating management's confidence in sustained momentum across its product portfolio, particularly in the rare disease segment.
• Industry ranking context: ANIP is currently the 6th highest-rated stock in the Pharmaceutical industry, which has an Industry Rating of B, positioning the company among the sector's top performers.
• Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr, with ANIP demonstrating exceptional growth metrics including 43.38% earnings growth (significantly above the industry average of 12.6%) and an impressive 52.15% return on equity that exceeds the industry average of 49.33%.
• Component Grades: The company earned an A in Value, reflecting attractive valuation at current levels, B in Sentiment from positive analyst coverage, B in Financials with healthy profit margins of 12.4% and strong operating cash flow of $58.4M, and C in Safety given its debt-to-equity ratio of 1.53. (See all 7 Zen Component Grades here)

3. Workiva (NYSE: WK)

Workiva provides cloud-based compliance and regulatory reporting solutions to companies in the U.S. and internationally, helping organizations streamline complex reporting workflows and ensure regulatory compliance. The company recently beat Q1 2026 earnings and revenue estimates, demonstrating continued momentum in its software-as-a-service business model with strong revenue growth visibility.

Zen Rating: Strong Buy (A) — see full analysis

Recent Price: $50.02 — get current quote

Max 1-year forecast: $90.00

Why we're watching:

• Analyst support: The stock has 3 Strong Buy and 1 Buy rating from 4 analysts, with an average price target of $80.25 representing nearly 60% upside potential from current levels. See the ratings
• Digging in a little deeper to the above, Brad Reback of Stifel Nicolaus (a top 15% ranked analyst based on stock-picking performance) maintains a Strong Buy rating with a price target that suggests nearly 40% upside in the coming year — while Baird and Truist Securities analysts assigned even higher targets of $86 and $90 respectively, reflecting broad confidence in Workiva's growth trajectory and market opportunity.
• The company beat Q1 earnings estimates and is demonstrating exceptional growth metrics with earnings expected to surge 1,137.79% year-over-year and revenue forecast to grow 15.6% as the platform gains traction with enterprise customers.
• Industry ranking context: WK is currently the 5th highest-rated stock in the App industry, which has an Industry Rating of B, positioning Workiva as a top-rated stock in a top-rated industry — a good place to be. 
• Zen Rating highlights: Strong Buy stocks have historically averaged around 30% returns annually, which is a good starting point if you’re looking for new watchlist picks. 
• Component Grades: The company earns an A in Growth driven by explosive earnings expansion, B in Sentiment from strong analyst support, B in Financials with solid operating fundamentals, and B in Artificial Intelligence reflecting its innovative technology platform, though the C in Safety reflects elevated debt levels. (See all 7 Zen Component Grades here)

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.